TrialX
PROPHET Study: ctDNA-Guided Personalized Induction Immunochemotherapy for NSCLC

PROPHET Study: ctDNA-Guided Personalized Induction Immunochemotherapy for NSCLC

Join the PROPHET Study: Personalized treatment for lung cancer research.

Recruiting
18-75 years
All
Phase 2

Study Purpose: This study is testing if a special blood test, called ctDNA, can help decide how many treatment cycles patients with a type of lung cancer, called NSCLC, need.

Who Can Join: We are looking for patients aged 18 and older with specific stages (IIA-IIIB) of NSCLC. The cancer must be resectable (can be removed by surgery) and you must have not received treatment before. You need to have good organ function and no recent serious illnesses.

What to Expect: If you join, you will receive 2 cycles of a combination of medicines (immunotherapy and chemotherapy) over 21-day periods. Depending on your test results (ctDNA), you might get 1-2 more cycles or go straight to surgery. Surgery will happen 4-6 weeks after the last treatment. The study involves a few visits over several weeks.

  • This study lasts several weeks and includes 2-4 treatment cycles and surgery.
  • You will need to visit the clinic for treatments and tests.
  • This study is for patients with early to advanced stages of NSCLC.

Note: Talk to your doctor to see if this study might be a suitable option for you.

Study details
    Non-small Cell Lung Cancer (NSCLC)

NCT06977074

Sun Yat-sen University

18 November 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.